110 related articles for article (PubMed ID: 6248185)
1. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns.
Bland KI; Buchanan JB; Weisberg BF; Hagan TA; Gray LA
Cancer; 1980 Jun; 45(12):3027-33. PubMed ID: 6248185
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma.
Bland KI; Kuhns JG; Buchanan JB; Dwyer PA; Heuser LF; O'Connor CA; Gray LA; Polk HC
Ann Surg; 1982 May; 195(5):582-94. PubMed ID: 7073355
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
4. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment.
Bergkvist L; Tabàr L; Adami HO; Persson I; Bergström R
Am J Epidemiol; 1989 Sep; 130(3):503-10. PubMed ID: 2763996
[TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
[TBL] [Abstract][Full Text] [Related]
6. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
[TBL] [Abstract][Full Text] [Related]
7. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
8. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
10. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.
Chlebowski RT; Anderson G; Pettinger M; Lane D; Langer RD; Gilligan MA; Walsh BW; Chen C; McTiernan A;
Arch Intern Med; 2008 Feb; 168(4):370-7; quiz 345. PubMed ID: 18299491
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
12. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
[TBL] [Abstract][Full Text] [Related]
13. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
[TBL] [Abstract][Full Text] [Related]
14. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
[TBL] [Abstract][Full Text] [Related]
15. Selected prognostic variables for mammographic parenchymal patterns.
Buchanan JB; Weisberg BF; Sandoz JP; Gray LA; Bland KI
Cancer; 1981 May; 47(9):2135-7. PubMed ID: 7226106
[TBL] [Abstract][Full Text] [Related]
16. Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy?
Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
Acta Oncol; 2000; 39(8):969-72. PubMed ID: 11207004
[TBL] [Abstract][Full Text] [Related]
17. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
18. Noncontraceptive estrogen use and the risk of breast cancer.
Kaufman DW; Miller DR; Rosenberg L; Helmrich SP; Stolley P; Schottenfeld D; Shapiro S
JAMA; 1984 Jul; 252(1):63-7. PubMed ID: 6328053
[TBL] [Abstract][Full Text] [Related]
19. Menopausal estrogen use and risk of breast cancer.
Brinton LA; Hoover RN; Szklo M; Fraumeni JF
Cancer; 1981 May; 47(10):2517-22. PubMed ID: 6268273
[TBL] [Abstract][Full Text] [Related]
20. Mammographic changes in women on hormonal replacement therapy.
Erel CT; Seyisoğlu H; Sentürk ML; Akman C; Ersavaşti G; Benian A; Uras C; Altuğ A; Ertüngealp E
Maturitas; 1996 Aug; 25(1):51-7. PubMed ID: 8887309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
